News Angle poised to take on US cancer diagnostics market Circulating tumour cell test could help select drug therapy.
News Theranos settles with investor on claims it lied about busin... Partner Fund Management agrees to drop lawsuits.
News Health insurer spots potential of Owlstone's lung cancer bre... The venture capital arm of the UK’s biggest insurance firm Aviva is to invest $5 million (£4m) in Owlstone Medical, one of the country’s most promising and potentially groundbreaking diagno
News 'Repeated violations' behind Theranos lab closure CMS report describes failures meeting its own quality control procedures.
News Abbott’s Zika blood test approved for emergency use Abbott's test is now the first to receive FDA commercial authorisation in an emergency use setting.
News Roche enters blood diagnostic market, promises faster result... Platform combines morphology analysis, cell counting and cell classification.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
